A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL

Patients with diffuse large B-cell lymphoma (DLBCL) have a median age of 70 years. Yet, empirical knowledge about the treatment of older patients is limited because they are frequently excluded from clinical trials. We aimed to construct a simplified frailty score and examine survival and treatment-...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaksen, Kathrine T., Mastroianni, Maria Adele, Rinde, Marit, Rusten, Leiv Sindre, Barzenje, Dlawer Abdulla, Ramslien, Lloyd Frode, Slaaen, Marit, Jerm, Marianne Brenn, Smeland, Erlend B., Rostoft, Siri, Liestøl, Knut, Brodtkorb, Marianne, Holte, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759139/
https://www.ncbi.nlm.nih.gov/pubmed/34543384
http://dx.doi.org/10.1182/bloodadvances.2021004777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759139/
https://www.ncbi.nlm.nih.gov/pubmed/34543384
http://dx.doi.org/10.1182/bloodadvances.2021004777

Ejemplares similares